SCHEMBL7986048

SCHEMBL7986048

CC(=O)NS(=O)(=O)c1ccc(N2N=C(C)C(=O)C(=O)C2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.48
DHFR P00374 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 4/20 0.47
POLB P06746 1/20 0.45
PKM P14618 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
HTT P42858 1/20 0.42
SCN3A Q9NY46 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974861 0.83 SMN1; SMN2 (0.51) KDM4ESMN1; SMN2TDP1ALDH1A1CA12
SCHEMBL7989125 0.78 CA9 (0.59) ALDH1A1PKMCA12CA1CA2
SCHEMBL7986767 0.77 PTGS2 (0.57) TDP1CA12CA1CA2CA9
SCHEMBL5931251 0.74 SMN1; SMN2 (0.69) KDM4ESMN1; SMN2DHFRTSHRTDP1
SCHEMBL7985179 0.74 POLB (0.62) SMN1; SMN2TSHRTDP1ALDH1A1POLB
SCHEMBL7985913 0.73 KAT8 (0.55) KDM4ESMN1; SMN2ALDH1A1POLBCA1
SCHEMBL28687948 0.72 SMN1; SMN2 (0.67) KDM4ESMN1; SMN2DHFRTSHRTDP1
SCHEMBL4613423 0.71 KDM4E (0.67) KDM4ESMN1; SMN2DHFRTSHRTDP1
SCHEMBL6736416 0.70 KMT2A (0.49) KDM4ESMN1; SMN2TDP1ALDH1A1POLB
SCHEMBL9325215 0.70 KDM4E (0.57) KDM4ESMN1; SMN2DHFRTSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821243-A 3,4,5-TRIOXO-2H,3H,4H,5H-PYRIDAZINES; TRANSCRIPTASE INHIBITORS; NONTOXIC VIROPHARMA INCORPORATED (US) 1998-10-13 US claimed
US-6271373-B1 PYRIDINE DERIVATIVE FORMED BY REACTING A PYRAZINE DERIVATIVE WITH FECL3 AND ACETIC ACID VIROPHARMA INCORPORATED 2001-08-07 US disclosed
US-6180628-B1 PYRIDAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH DERIVATIVES AND THEIR USE IN TREATING INFLUENZA INFECTION AND OTHER VIRAL DISEASES VIROPHARMA INCORPORATED 2001-01-30 US disclosed
US-5935957-A PYRIDAZINE DERIVATIVES VIROPHARMA INCORPORATED (US) 1999-08-10 US disclosed